Amundi Asset Management US’s Amedisys AMED Stock Holding History

Amundi Asset Management US’s Portfolio AMED Stock Details AMED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	$29.9M	Buy	112,889 +9,401	+9%	+$2.65M	0.02%	564
2020 Q4	$30.4M	Sell	103,488 -976	-0.9%	-$250K	0.03%	526
2020 Q3	$24.7M	Buy	104,464 +3,129	+3%	+$711K	0.03%	493
2020 Q2	$20.1M	Sell	101,335 -19,241	-16%	-$3.59M	0.02%	506
2020 Q1	$22.1M	Sell	120,576 -9,955	-8%	-$1.77M	0.04%	382
2019 Q4	$21.8M	Buy	130,531 +10,058	+8%	+$1.5M	0.03%	531
2019 Q3	$15.8M	Buy	120,473 +7,492	+7%	+$975K	0.02%	574
2019 Q2	$13.7M	Sell	112,981 -1,456	-1%	-$173K	0.01%	692
2019 Q1	$14.1M	Sell	114,437 -371	-0.3%	-$46.6K	0.02%	628
2018 Q4	$13.4K	Sell	114,808 -293	-0.3%	-$34.5K	0.01%	570
2018 Q3	$14.4M	Buy	+115,101	New	+$12.7M	0.02%	644
2016 Q3	–	Sell	-52,747	Closed	-$2.66M	–	539
2016 Q2	$2.66M	Buy	+52,747	New	+$2.66M	0.01%	485

Other funds holding AMED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

Amundi Asset Management US's AMED Position: Q1 2021 in Review

Amundi Asset Management US increased its Amedisys (AMED) stake by 9.1% in Q1 2021, buying an estimated $2.65M and bringing the position to 112,889 shares worth $29.9M. The position accounts for 0.02% of the portfolio, ranked #564.

Amundi Asset Management US first reported a position in AMED in Q2 2016 and has held it in 12 quarters since. The position peaked at $30.4M in Q4 2020. 389 funds tracked by Wall St. Rank hold AMED as of Q1 2021.

Amundi Asset Management US held 112,889 shares of Amedisys worth $29.9M as of Q1 2021.
Amundi Asset Management US bought 9,401 Amedisys shares in Q1 2021, an estimated $2.65M.
Amedisys made up 0.02% of Amundi Asset Management US's portfolio in Q1 2021, its #564 holding.
Amundi Asset Management US first reported a position in Amedisys in Q2 2016 and has held it in 12 quarters since.
Amundi Asset Management US's Amedisys position peaked at $30.4M in Q4 2020.
389 funds tracked by Wall St. Rank held Amedisys as of Q1 2021.

Based on Amundi Asset Management US's 13F filing for Q1 2021, filed 17 May 2021.